Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2012

01.02.2012

Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44

verfasst von: Orly Shimony, Arnon Nagler, Yechiel N. Gellman, Efrat Refaeli, Nir Rosenblum, Lora Eshkar-Sebban, Ronit Yerushalmi, Avichai Shimoni, Simon D. Lytton, Anfisa Stanevsky, Reuven Or, David Naor

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

We show here that the anti-T lymphocyte immunoglobulin (ATG) can induce Treg cells following 24-h incubation in human peripheral blood mononuclear cells (PBMCs). The ATG-induced Treg cells express known cell surface markers (e.g., CD25, FoxP3) and suppress the proliferation of autologous responder PBMCs, stimulated with allogeneic PBMCs, when added into the mixed lymphocyte culture (MLC) at zero time point or 48 h later. We expanded the characteristics of the ATG-induced human Treg cells by showing that they express a novel biomarker designated “activated CD44”. ATG-induced Treg cells retain their suppressor function after freezing and thawing or irradiation. Suppression of MLC by ATG-induced Treg cells is consistently seen when the Treg cells and the responder cells were derived from the same donor, but not when they derived from different donors. Finally, patients undergoing stem cell transplantation and conditioned with ATG generate in vivo Treg cells that suppress MLC.
Literatur
1.
Zurück zum Zitat Mothy M. Mechanism of action of antithymocyte globulin: T cell depletion and beyond. Leukemia. 2007;21:1387–94.CrossRef Mothy M. Mechanism of action of antithymocyte globulin: T cell depletion and beyond. Leukemia. 2007;21:1387–94.CrossRef
2.
Zurück zum Zitat Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–32.PubMedCrossRef Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–32.PubMedCrossRef
3.
Zurück zum Zitat Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+FoxP3+ regulatory T cells. J Am Soc Nephrol. 2006;17:2844–53.PubMedCrossRef Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+FoxP3+ regulatory T cells. J Am Soc Nephrol. 2006;17:2844–53.PubMedCrossRef
4.
Zurück zum Zitat Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+. Blood. 2008;111:3675–83.PubMedCrossRef Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+. Blood. 2008;111:3675–83.PubMedCrossRef
5.
Zurück zum Zitat Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, et al. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood. 2008;111:1726–34.PubMedCrossRef Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, et al. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood. 2008;111:1726–34.PubMedCrossRef
6.
Zurück zum Zitat Broady R, Yu J, Levings MK. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood. 2009;114:5003–6.PubMedCrossRef Broady R, Yu J, Levings MK. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood. 2009;114:5003–6.PubMedCrossRef
7.
Zurück zum Zitat Vogt Sionov R, Naor D. Hyaluronan-independent lodgement of CD44+ lymphoma cells in lymphoid organs. Int J Cancer. 1997;71:462–9.PubMedCrossRef Vogt Sionov R, Naor D. Hyaluronan-independent lodgement of CD44+ lymphoma cells in lymphoid organs. Int J Cancer. 1997;71:462–9.PubMedCrossRef
8.
Zurück zum Zitat Naor D, Vogt Sionov R, Ish-Shalom D. CD44: structure, function and its association with the malignant process. Adv Cancer Res. 1997;71:241–319.PubMedCrossRef Naor D, Vogt Sionov R, Ish-Shalom D. CD44: structure, function and its association with the malignant process. Adv Cancer Res. 1997;71:241–319.PubMedCrossRef
9.
Zurück zum Zitat Naor D, Nedvetzki S, Golan I, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci. 2002;39:527–79.PubMedCrossRef Naor D, Nedvetzki S, Golan I, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci. 2002;39:527–79.PubMedCrossRef
10.
Zurück zum Zitat Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond L, et al. RHAMM, a receptor for hyaluronan-mediated motility compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA. 2004;101:18081–6.PubMedCrossRef Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond L, et al. RHAMM, a receptor for hyaluronan-mediated motility compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA. 2004;101:18081–6.PubMedCrossRef
11.
12.
Zurück zum Zitat Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 2006;107:619–27.PubMedCrossRef Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 2006;107:619–27.PubMedCrossRef
13.
Zurück zum Zitat Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, et al. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol. 2007;179:744–7.PubMed Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, et al. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol. 2007;179:744–7.PubMed
14.
Zurück zum Zitat Liu T, Soong L, Liu G, König R, Chopra AK. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells. Biol Direct. 2009;4:40.PubMedCrossRef Liu T, Soong L, Liu G, König R, Chopra AK. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells. Biol Direct. 2009;4:40.PubMedCrossRef
15.
Zurück zum Zitat Min B, Thornton A, Caucheteux SM, Younes SA, Oh K, Hu-Li J, et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol. 2007;37:1916–23.PubMedCrossRef Min B, Thornton A, Caucheteux SM, Younes SA, Oh K, Hu-Li J, et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol. 2007;37:1916–23.PubMedCrossRef
16.
Zurück zum Zitat Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140:845–58.PubMedCrossRef Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140:845–58.PubMedCrossRef
17.
Zurück zum Zitat Chung DT, Korn T, Richard J, Ruzek M, Kohm AP, Miller S, et al. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expending myelin antigen-specific FoxPox3+ regulatory T cells. Int Immunol. 2007;19:1003–10.PubMedCrossRef Chung DT, Korn T, Richard J, Ruzek M, Kohm AP, Miller S, et al. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expending myelin antigen-specific FoxPox3+ regulatory T cells. Int Immunol. 2007;19:1003–10.PubMedCrossRef
18.
Zurück zum Zitat Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and IL-17 cells. Annu Rev Immunol. 2009;27:485–517.PubMedCrossRef Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and IL-17 cells. Annu Rev Immunol. 2009;27:485–517.PubMedCrossRef
19.
Zurück zum Zitat Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, et al. Regulatory T-cell in Graves’ orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011;96:422–9.PubMedCrossRef Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, et al. Regulatory T-cell in Graves’ orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011;96:422–9.PubMedCrossRef
Metadaten
Titel
Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44
verfasst von
Orly Shimony
Arnon Nagler
Yechiel N. Gellman
Efrat Refaeli
Nir Rosenblum
Lora Eshkar-Sebban
Ronit Yerushalmi
Avichai Shimoni
Simon D. Lytton
Anfisa Stanevsky
Reuven Or
David Naor
Publikationsdatum
01.02.2012
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2012
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9599-2

Weitere Artikel der Ausgabe 1/2012

Journal of Clinical Immunology 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.